Parkwalk Advisors

Parkwalk Advisors Ltd is a prominent United Kingdom venture capital firm based in London, United Kingdom, specialising in UK university spin-out investing, particularly through tax-advantaged Enterprise Investment Scheme (EIS) funds that enable UK private-wealth investors to access early- and growth-stage university-research-commercialisation opportunities with tax-relief benefits. The firm was founded in 2009 by Alastair Kilgour and Moray Wright (Co-Founders and Managing Partners) and invests in early- and growth-stage companies across healthcare / biotech, clean energy and climate-tech, advanced materials, engineering / deep-tech, artificial intelligence, quantum computing, and adjacent deep-science-and-technology themes aEUR" sourced predominantly from leading UK university research programmes at Oxford, Cambridge, Imperial, UCL, Edinburgh, and other research-intensive UK institutions. In December 2017, Parkwalk Advisors was acquired by IP Group plc (LSE: IPO), the listed UK university-IP commercialisation investor, and now operates as the EIS-fund-management arm of the broader IP Group platform. Parkwalk manages the largest EIS funds dedicated to UK university spin-outs, with aggregate AUM in the GBP several-hundred-million range across multiple EIS vintages and a ''Parkwalk Opportunities'' evergreen vehicle. Notable portfolio companies include Nexeon (battery technology), Oxford Nanopore Technologies (LSE: ONT, via co-investment), Featurespace, Creavo Medical Technologies, and many other UK university spin-outs.